25 XP   0   0   10

Ahn-Gook Pharmaceutical Co. Ltd
Buy, Hold or Sell?

Let's analyse Ahn-gook together

PenkeI guess you are interested in Ahn-Gook Pharmaceutical Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ahn-Gook Pharmaceutical Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ahn-Gook Pharmaceutical Co. Ltd

I send you an email if I find something interesting about Ahn-Gook Pharmaceutical Co. Ltd.

Quick analysis of Ahn-gook (30 sec.)










What can you expect buying and holding a share of Ahn-gook? (30 sec.)

How much money do you get?

How much money do you get?
₩0.30
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
₩13,406.71
Expected worth in 1 year
₩13,362.54
How sure are you?
72.5%

+ What do you gain per year?

Total Gains per Share
₩391.21
Return On Investment
4.7%

For what price can you sell your share?

Current Price per Share
₩8,320.00
Expected price per share
₩8,300 - ₩10,254
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Ahn-gook (5 min.)




Live pricePrice per Share (EOD)

₩8,320.00

Intrinsic Value Per Share

₩-40,181.74 - ₩-47,942.44

Total Value Per Share

₩-26,775.04 - ₩-34,535.73

2. Growth of Ahn-gook (5 min.)




Is Ahn-gook growing?

Current yearPrevious yearGrowGrow %
How rich?$108m$102.9m$5.3m4.9%

How much money is Ahn-gook making?

Current yearPrevious yearGrowGrow %
Making money$801.7k$1.6m-$855.7k-106.7%
Net Profit Margin2.0%4.8%--

How much money comes from the company's main activities?

3. Financial Health of Ahn-gook (5 min.)




3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Ahn-gook? (5 min.)

Welcome investor! Ahn-gook's management wants to use your money to grow the business. In return you get a share of Ahn-gook.

What can you expect buying and holding a share of Ahn-gook?

First you should know what it really means to hold a share of Ahn-gook. And how you can make/lose money.

Speculation

The Price per Share of Ahn-gook is ₩8,320. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ahn-gook.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ahn-gook, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩13,406.71. Based on the TTM, the Book Value Change Per Share is ₩-11.04 per quarter. Based on the YOY, the Book Value Change Per Share is ₩255.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩108.84 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ahn-gook.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.040.0%0.070.0%0.140.0%0.070.0%0.090.0%
Usd Book Value Change Per Share-0.040.0%-0.010.0%0.180.0%0.040.0%0.050.0%
Usd Dividend Per Share0.000.0%0.080.0%0.110.0%0.090.0%0.090.0%
Usd Total Gains Per Share-0.040.0%0.070.0%0.290.0%0.130.0%0.140.0%
Usd Price Per Share5.43-5.76-6.59-7.55-8.97-
Price to Earnings Ratio33.91-31.28-15.25-25.42-23.89-
Price-to-Total Gains Ratio-122.21--117.72--5.09--43.79-73.05-
Price to Book Ratio0.58-0.61-0.74-0.85-1.08-
Price-to-Total Gains Ratio-122.21--117.72--5.09--43.79-73.05-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.824
Number of shares171
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.080.09
Usd Book Value Change Per Share-0.010.04
Usd Total Gains Per Share0.070.13
Gains per Quarter (171 shares)11.7122.99
Gains per Year (171 shares)46.8391.94
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
152-537632982
2104-118412757174
3156-1613119086266
4208-21178253115358
5261-26225317143450
6313-32272380172542
7365-37319443200634
8417-42366506229726
9469-48413570258818
10521-53460633286910

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%17.03.00.085.0%32.04.04.080.0%34.04.05.079.1%
Book Value Change Per Share1.03.00.025.0%5.07.00.041.7%11.09.00.055.0%24.016.00.060.0%27.016.00.062.8%
Dividend per Share2.00.02.050.0%9.00.03.075.0%17.00.03.085.0%32.00.08.080.0%34.00.09.079.1%
Total Gains per Share2.02.00.050.0%7.05.00.058.3%13.07.00.065.0%29.011.00.072.5%32.011.00.074.4%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Ahn-gook

About Ahn-Gook Pharmaceutical Co. Ltd

Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-02-09 10:16:07.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Ahn-Gook Pharmaceutical Co. Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ahn-gook earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Ahn-gook to the  industry mean.
  • A Net Profit Margin of 1.2% means that ₩0.01 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 1.2%. The company is making a profit. +1
  • The TTM is 2.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.2%TTM2.0%-0.9%
TTM2.0%YOY4.8%-2.7%
TTM2.0%5Y2.2%-0.1%
5Y2.2%10Y3.1%-1.0%
1.1.2. Return on Assets

Shows how efficient Ahn-gook is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ahn-gook to the  industry mean.
  • 0.3% Return on Assets means that Ahn-gook generated ₩0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.5%-0.2%
TTM0.5%YOY1.1%-0.6%
TTM0.5%5Y0.5%+0.0%
5Y0.5%10Y0.7%-0.2%
1.1.3. Return on Equity

Shows how efficient Ahn-gook is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ahn-gook to the  industry mean.
  • 0.4% Return on Equity means Ahn-gook generated ₩0.00 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 0.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.4%TTM0.7%-0.3%
TTM0.7%YOY1.6%-0.9%
TTM0.7%5Y0.7%+0.0%
5Y0.7%10Y1.0%-0.3%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Ahn-Gook Pharmaceutical Co. Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ahn-gook is operating .

  • Measures how much profit Ahn-gook makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ahn-gook to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.6%-2.6%
TTM2.6%YOY2.9%-0.3%
TTM2.6%5Y1.8%+0.8%
5Y1.8%10Y1.7%+0.1%
1.2.2. Operating Ratio

Measures how efficient Ahn-gook is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.39 means that the operating costs are ₩1.39 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 1.393. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.553. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ1.393TTM0.553+0.840
TTM0.553YOY0.384+0.169
TTM0.5535Y0.691-0.138
5Y0.69110Y0.758-0.067
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Ahn-Gook Pharmaceutical Co. Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ahn-gook is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.90 means the company has ₩1.90 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 1.900. The company is able to pay all its short-term debts. +1
  • The TTM is 1.948. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.900TTM1.948-0.048
TTM1.948YOY2.121-0.173
TTM1.9485Y2.420-0.472
5Y2.42010Y1.596+0.824
1.3.2. Quick Ratio

Measures if Ahn-gook is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ahn-gook to the  industry mean.
  • A Quick Ratio of 1.21 means the company can pay off ₩1.21 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 1.210. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.602. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.210TTM1.602-0.392
TTM1.602YOY2.027-0.425
TTM1.6025Y2.127-0.525
5Y2.12710Y1.770+0.358
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Ahn-Gook Pharmaceutical Co. Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ahn-gook assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ahn-gook to industry mean.
  • A Debt to Asset Ratio of 0.32 means that Ahn-gook assets are financed with 32.2% credit (debt) and the remaining percentage (100% - 32.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 0.322. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.313. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.322TTM0.313+0.009
TTM0.313YOY0.310+0.004
TTM0.3135Y0.308+0.005
5Y0.30810Y0.305+0.003
1.4.2. Debt to Equity Ratio

Measures if Ahn-gook is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ahn-gook to the  industry mean.
  • A Debt to Equity ratio of 47.6% means that company has ₩0.48 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The MRQ is 0.476. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.456. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.476TTM0.456+0.019
TTM0.456YOY0.448+0.008
TTM0.4565Y0.446+0.011
5Y0.44610Y0.441+0.004
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Ahn-Gook Pharmaceutical Co. Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Ahn-gook generates.

  • Above 15 is considered overpriced but always compare Ahn-gook to the  industry mean.
  • A PE ratio of 33.91 means the investor is paying ₩33.91 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The EOD is 36.407. Based on the earnings, the company is overpriced. -1
  • The MRQ is 33.913. Based on the earnings, the company is overpriced. -1
  • The TTM is 31.283. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD36.407MRQ33.913+2.494
MRQ33.913TTM31.283+2.630
TTM31.283YOY15.250+16.033
TTM31.2835Y25.416+5.867
5Y25.41610Y23.893+1.523
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The EOD is -2.361. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.199. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 39.317. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD-2.361MRQ-2.199-0.162
MRQ-2.199TTM39.317-41.516
TTM39.317YOY-13.267+52.584
TTM39.3175Y0.958+38.359
5Y0.95810Y-1.379+2.337
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ahn-gook is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 0.58 means the investor is paying ₩0.58 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Ahn-Gook Pharmaceutical Co. Ltd:

  • The EOD is 0.621. Based on the equity, the company is cheap. +2
  • The MRQ is 0.578. Based on the equity, the company is cheap. +2
  • The TTM is 0.613. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.621MRQ0.578+0.043
MRQ0.578TTM0.613-0.035
TTM0.613YOY0.740-0.127
TTM0.6135Y0.847-0.234
5Y0.84710Y1.080-0.233
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Ahn-Gook Pharmaceutical Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---63.415-11.041-83%255.128-125%59.804-206%76.394-183%
Book Value Per Share--13406.70513438.6430%12778.329+5%12811.019+5%12070.391+11%
Current Ratio--1.9001.948-2%2.121-10%2.420-21%1.596+19%
Debt To Asset Ratio--0.3220.313+3%0.310+4%0.308+5%0.305+6%
Debt To Equity Ratio--0.4760.456+4%0.448+6%0.446+7%0.441+8%
Dividend Per Share---108.843-100%163.829-100%132.225-100%130.514-100%
Eps--57.13199.499-43%205.702-72%94.559-40%124.599-54%
Free Cash Flow Per Share---881.018-225.905-74%-34.194-96%-39.792-95%161.509-645%
Free Cash Flow To Equity Per Share---881.018-327.200-63%-196.116-78%-60.286-93%185.809-574%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.900+11%
Intrinsic Value_10Y_max---47942.437--------
Intrinsic Value_10Y_min---40181.744--------
Intrinsic Value_1Y_max---1617.969--------
Intrinsic Value_1Y_min---1587.365--------
Intrinsic Value_3Y_max---7289.597--------
Intrinsic Value_3Y_min---6910.230--------
Intrinsic Value_5Y_max---15888.792--------
Intrinsic Value_5Y_min---14538.570--------
Market Cap95770688000.000+7%89209475000.00094792261500.000-6%108346346250.000-18%124307541850.000-28%147964126528.777-40%
Net Profit Margin--0.0120.020-42%0.048-75%0.022-45%0.031-62%
Operating Margin---0.026-100%0.029-100%0.018-100%0.017-100%
Operating Ratio--1.3930.553+152%0.384+262%0.691+102%0.758+84%
Pb Ratio0.621+7%0.5780.613-6%0.740-22%0.847-32%1.080-46%
Pe Ratio36.407+7%33.91331.283+8%15.250+122%25.416+33%23.893+42%
Price Per Share8320.000+7%7750.0008235.000-6%9412.500-18%10791.500-28%12812.500-40%
Price To Free Cash Flow Ratio-2.361-7%-2.19939.317-106%-13.267+503%0.958-330%-1.379-37%
Price To Total Gains Ratio-131.199-7%-122.210-117.718-4%-5.086-96%-43.789-64%73.049-267%
Quick Ratio--1.2101.602-24%2.027-40%2.127-43%1.770-32%
Return On Assets--0.0030.005-43%0.011-74%0.005-43%0.007-61%
Return On Equity--0.0040.007-43%0.016-73%0.007-42%0.010-59%
Total Gains Per Share---63.41597.802-165%418.957-115%192.029-133%206.908-131%
Usd Book Value--108026272.172108283609.8120%102963049.179+5%103304526.863+5%97542335.334+11%
Usd Book Value Change Per Share---0.044-0.008-83%0.179-125%0.042-206%0.053-183%
Usd Book Value Per Share--9.3859.4070%8.945+5%8.968+5%8.449+11%
Usd Dividend Per Share---0.076-100%0.115-100%0.093-100%0.091-100%
Usd Eps--0.0400.070-43%0.144-72%0.066-40%0.087-54%
Usd Free Cash Flow---7098918.554-1820255.061-74%-275521.477-96%-321589.508-95%1208238.174-688%
Usd Free Cash Flow Per Share---0.617-0.158-74%-0.024-96%-0.028-95%0.113-645%
Usd Free Cash Flow To Equity Per Share---0.617-0.229-63%-0.137-78%-0.042-93%0.130-574%
Usd Market Cap67039481.600+7%62446632.50066354583.050-6%75842442.375-18%87015279.295-28%103574888.570-40%
Usd Price Per Share5.824+7%5.4255.765-6%6.589-18%7.554-28%8.969-40%
Usd Profit--460344.451801727.820-43%1657472.023-72%764986.979-40%1010105.751-54%
Usd Revenue--38745998.75339582625.534-2%34254523.772+13%31317091.519+24%31251333.634+24%
Usd Total Gains Per Share---0.0440.068-165%0.293-115%0.134-133%0.145-131%
 EOD+4 -4MRQTTM+3 -32YOY+6 -295Y+7 -2810Y+9 -27

3.2. Fundamental Score

Let's check the fundamental score of Ahn-Gook Pharmaceutical Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1536.407
Price to Book Ratio (EOD)Between0-10.621
Net Profit Margin (MRQ)Greater than00.012
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.210
Current Ratio (MRQ)Greater than11.900
Debt to Asset Ratio (MRQ)Less than10.322
Debt to Equity Ratio (MRQ)Less than10.476
Return on Equity (MRQ)Greater than0.150.004
Return on Assets (MRQ)Greater than0.050.003
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Ahn-Gook Pharmaceutical Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.962
Ma 20Greater thanMa 508,798.500
Ma 50Greater thanMa 1008,911.946
Ma 100Greater thanMa 2008,217.059
OpenGreater thanClose8,450.000
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Operating Income  4,556,222-2,807,5551,748,6681,982,9403,731,607-3,050,396681,211-699,237-18,026



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets227,779,451
Total Liabilities73,456,205
Total Stockholder Equity154,461,562
 As reported
Total Liabilities 73,456,205
Total Stockholder Equity+ 154,461,562
Total Assets = 227,779,451

Assets

Total Assets227,779,451
Total Current Assets123,717,816
Long-term Assets104,061,635
Total Current Assets
Cash And Cash Equivalents 5,721,732
Short-term Investments 21,554,266
Net Receivables 57,211,858
Inventory 35,457,173
Other Current Assets 150,656
Total Current Assets  (as reported)123,717,816
Total Current Assets  (calculated)120,095,684
+/- 3,622,132
Long-term Assets
Property Plant Equipment 72,174,179
Intangible Assets 4,289,452
Long-term Assets Other 0
Long-term Assets  (as reported)104,061,635
Long-term Assets  (calculated)76,463,631
+/- 27,598,003

Liabilities & Shareholders' Equity

Total Current Liabilities65,105,748
Long-term Liabilities8,350,458
Total Stockholder Equity154,461,562
Total Current Liabilities
Short Long Term Debt 20,300,000
Accounts payable 15,117,055
Total Current Liabilities  (as reported)65,105,748
Total Current Liabilities  (calculated)35,417,055
+/- 29,688,693
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt420,948
Long-term Liabilities  (as reported)8,350,458
Long-term Liabilities  (calculated)420,948
+/- 7,929,510
Total Stockholder Equity
Retained Earnings 135,030,447
Total Stockholder Equity (as reported)154,461,562
Total Stockholder Equity (calculated)135,030,447
+/- 19,431,115
Other
Capital Stock6,521,210
Common Stock Shares Outstanding 11,365
Net Debt 14,578,268
Net Invested Capital 174,761,562
Net Working Capital 58,612,069
Property Plant and Equipment Gross 117,951,665



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
171,653,349
156,162,744
155,687,469
163,242,179
170,330,222
171,218,294
171,809,751
179,070,463
171,925,196
177,005,690
192,802,181
197,854,693
195,525,748
184,987,269
187,320,466
196,267,318
197,842,324
194,950,963
194,617,803
208,065,058
206,586,872
201,204,298
204,578,263
212,923,583
215,621,407
219,988,569
216,835,239
217,956,961
213,038,253
211,339,939
201,473,633
201,701,794
202,660,588
199,067,834
201,292,965
211,796,191
210,029,866
208,502,172
221,699,852
223,912,434
222,782,033
226,597,387
227,779,451
227,779,451226,597,387222,782,033223,912,434221,699,852208,502,172210,029,866211,796,191201,292,965199,067,834202,660,588201,701,794201,473,633211,339,939213,038,253217,956,961216,835,239219,988,569215,621,407212,923,583204,578,263201,204,298206,586,872208,065,058194,617,803194,950,963197,842,324196,267,318187,320,466184,987,269195,525,748197,854,693192,802,181177,005,690171,925,196179,070,463171,809,751171,218,294170,330,222163,242,179155,687,469156,162,744171,653,349
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124,342,573
123,345,460
133,218,143
130,342,198
128,602,406
130,189,836
148,767,155
150,348,479
154,423,114
150,481,862
152,138,901
147,348,151
146,547,786
133,001,817
111,432,212
113,461,327
109,045,682
110,624,382
116,284,605
113,640,802
112,893,715
119,439,932
122,009,639
119,730,201
122,776,191
123,717,816
123,717,816122,776,191119,730,201122,009,639119,439,932112,893,715113,640,802116,284,605110,624,382109,045,682113,461,327111,432,212133,001,817146,547,786147,348,151152,138,901150,481,862154,423,114150,348,479148,767,155130,189,836128,602,406130,342,198133,218,143123,345,460124,342,57300000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,313,811
22,445,220
22,640,064
22,061,033
25,940,798
21,371,008
21,471,866
25,712,811
19,701,814
26,522,118
22,744,999
26,102,060
32,577,232
24,312,197
11,209,233
7,647,405
9,564,075
9,201,635
2,874,244
9,658,496
8,966,967
3,618,116
10,343,174
3,482,272
5,071,493
5,721,732
5,721,7325,071,4933,482,27210,343,1743,618,1168,966,9679,658,4962,874,2449,201,6359,564,0757,647,40511,209,23324,312,19732,577,23226,102,06022,744,99926,522,11819,701,81425,712,81121,471,86621,371,00825,940,79822,061,03322,640,06422,445,22026,313,81100000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,842,083
12,395,726
13,237,870
17,250,902
11,155,900
12,053,367
12,942,516
13,848,125
18,759,730
19,958,331
20,896,703
0
0
47,074,199
35,823,867
38,368,056
30,570,782
32,380,568
32,559,458
23,422,326
17,372,595
23,631,390
17,873,023
22,903,153
19,743,173
21,554,266
21,554,26619,743,17322,903,15317,873,02323,631,39017,372,59523,422,32632,559,45832,380,56830,570,78238,368,05635,823,86747,074,1990020,896,70319,958,33118,759,73013,848,12512,942,51612,053,36711,155,90017,250,90213,237,87012,395,7267,842,08300000000000000000
       Net Receivables 
39,616,592
38,959,881
34,476,474
41,712,110
43,394,292
45,568,125
48,314,138
53,244,526
52,940,566
50,463,436
51,185,727
62,805,179
52,727,146
49,073,431
46,333,407
56,853,457
58,515,428
52,516,424
54,728,152
62,351,575
52,377,341
49,724,814
57,350,150
69,200,423
62,895,824
54,936,695
41,824,458
45,809,670
39,425,541
38,279,978
37,538,304
37,737,378
37,696,923
38,578,099
37,981,248
43,380,636
43,080,324
44,655,792
47,466,576
55,596,541
48,754,203
50,771,060
57,211,858
57,211,85850,771,06048,754,20355,596,54147,466,57644,655,79243,080,32443,380,63637,981,24838,578,09937,696,92337,737,37837,538,30438,279,97839,425,54145,809,67041,824,45854,936,69562,895,82469,200,42357,350,15049,724,81452,377,34162,351,57554,728,15252,516,42458,515,42856,853,45746,333,40749,073,43152,727,14662,805,17951,185,72750,463,43652,940,56653,244,52648,314,13845,568,12543,394,29241,712,11034,476,47438,959,88139,616,592
       Other Current Assets 
1,297,047
495,194
467,099
466,152
921,568
1,455,576
623,264
3,380,980
3,023,393
6,101,951
2,924,489
1,766,993
1,716,675
1,373,650
3,610,212
2,795,248
3,801,233
1,796,641
1,956,485
2,797,427
5,908,912
2,047,743
4,177,788
2,141,893
2,176,357
1,508,358
853,899
3,014,783
3,023,090
758,012
451,920
545,920
1,452,521
239,966
493,741
1,435,452
1,441,509
1,133,731
823,865
1,302,462
1,587,187
2,500,657
150,656
150,6562,500,6571,587,1871,302,462823,8651,133,7311,441,5091,435,452493,741239,9661,452,521545,920451,920758,0123,023,0903,014,783853,8991,508,3582,176,3572,141,8934,177,7882,047,7435,908,9122,797,4271,956,4851,796,6413,801,2332,795,2483,610,2121,373,6501,716,6751,766,9932,924,4896,101,9513,023,3933,380,980623,2641,455,576921,568466,152467,099495,1941,297,047
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
101,902,794
103,051,832
103,821,195
104,061,635
104,061,635103,821,195103,051,832101,902,794000000000000000000000000000000000000000
       Property Plant Equipment 
40,570,485
40,508,131
43,523,722
45,311,178
45,475,858
49,202,564
49,349,666
49,659,031
49,013,108
48,705,789
48,123,119
49,337,340
48,897,054
48,709,530
50,883,112
50,520,372
50,471,276
49,442,827
50,065,312
49,137,924
47,127,871
46,659,226
46,716,676
46,839,168
47,972,184
47,860,261
48,342,012
48,036,054
49,497,309
49,103,322
49,854,977
70,554,480
69,940,684
70,575,078
71,048,540
70,911,014
70,859,577
70,329,936
70,313,839
70,770,770
71,478,038
71,348,702
72,174,179
72,174,17971,348,70271,478,03870,770,77070,313,83970,329,93670,859,57770,911,01471,048,54070,575,07869,940,68470,554,48049,854,97749,103,32249,497,30948,036,05448,342,01247,860,26147,972,18446,839,16846,716,67646,659,22647,127,87149,137,92450,065,31249,442,82750,471,27650,520,37250,883,11248,709,53048,897,05449,337,34048,123,11948,705,78949,013,10849,659,03149,349,66649,202,56445,475,85845,311,17843,523,72240,508,13140,570,485
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,093,887
16,012,851
19,091,900
20,943,095
17,704,706
19,649,374
8,173,251
8,370,227
8,999,182
9,504,184
9,070,824
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000009,070,8249,504,1848,999,1828,370,2278,173,25119,649,37417,704,70620,943,09519,091,90016,012,85116,093,88700000000000000000
       Intangible Assets 
4,409,459
4,023,712
4,050,398
3,910,702
4,584,045
3,911,162
3,887,506
2,987,270
2,976,462
2,931,172
2,851,072
3,117,532
2,942,235
2,656,186
2,717,244
2,606,714
2,546,989
2,656,054
2,585,593
2,502,901
4,144,694
4,285,555
4,122,481
4,117,363
3,969,735
3,857,260
3,736,046
3,579,140
3,477,294
3,449,851
3,346,116
3,378,322
3,372,717
3,674,861
3,804,724
3,873,872
3,891,333
3,916,528
4,149,252
4,086,533
4,220,210
4,306,334
4,289,452
4,289,4524,306,3344,220,2104,086,5334,149,2523,916,5283,891,3333,873,8723,804,7243,674,8613,372,7173,378,3223,346,1163,449,8513,477,2943,579,1403,736,0463,857,2603,969,7354,117,3634,122,4814,285,5554,144,6942,502,9012,585,5932,656,0542,546,9892,606,7142,717,2442,656,1862,942,2353,117,5322,851,0722,931,1722,976,4622,987,2703,887,5063,911,1624,584,0453,910,7024,050,3984,023,7124,409,459
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000
> Total Liabilities 
55,919,839
39,562,930
36,538,761
36,820,210
43,086,326
45,559,959
43,613,469
56,605,918
49,233,230
49,910,432
59,706,247
65,961,117
65,641,064
55,758,581
58,012,426
64,920,585
67,187,336
61,642,917
57,168,202
70,612,462
69,632,355
60,990,390
62,852,002
65,704,798
69,405,785
73,965,713
69,906,703
69,710,446
64,025,886
66,831,652
56,670,054
57,603,379
59,965,800
57,468,027
58,208,377
66,535,268
66,414,599
63,849,673
66,868,261
69,114,736
68,192,704
71,544,175
73,456,205
73,456,20571,544,17568,192,70469,114,73666,868,26163,849,67366,414,59966,535,26858,208,37757,468,02759,965,80057,603,37956,670,05466,831,65264,025,88669,710,44669,906,70373,965,71369,405,78565,704,79862,852,00260,990,39069,632,35570,612,46257,168,20261,642,91767,187,33664,920,58558,012,42655,758,58165,641,06465,961,11759,706,24749,910,43249,233,23056,605,91843,613,46945,559,95943,086,32636,820,21036,538,76139,562,93055,919,839
   > Total Current Liabilities 
46,691,967
30,618,051
27,319,628
27,335,173
30,596,508
32,459,908
30,090,677
42,480,722
34,790,601
34,875,153
32,949,587
38,359,461
37,789,539
28,649,564
30,720,680
51,369,176
53,922,319
48,820,065
39,776,307
58,391,130
57,251,173
48,505,559
50,287,922
52,068,001
55,162,546
59,344,492
55,346,220
56,282,378
50,603,524
53,231,260
43,463,619
44,678,365
48,791,907
43,883,941
44,543,284
52,212,214
57,164,748
53,029,930
55,829,628
61,498,455
60,520,767
63,593,675
65,105,748
65,105,74863,593,67560,520,76761,498,45555,829,62853,029,93057,164,74852,212,21444,543,28443,883,94148,791,90744,678,36543,463,61953,231,26050,603,52456,282,37855,346,22059,344,49255,162,54652,068,00150,287,92248,505,55957,251,17358,391,13039,776,30748,820,06553,922,31951,369,17630,720,68028,649,56437,789,53938,359,46132,949,58734,875,15334,790,60142,480,72230,090,67732,459,90830,596,50827,335,17327,319,62830,618,05146,691,967
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,435,896
409,450
1,025,700
738,030
621,890
422,430
153,380
153,380
121,030
18,000,000
18,000,000
17,400,000
17,544,720
19,900,000
19,900,000
19,866,000
19,800,000
19,600,000
19,600,000
19,600,000
19,600,000
19,450,000
19,450,000
16,850,000
20,350,000
0
020,350,00016,850,00019,450,00019,450,00019,600,00019,600,00019,600,00019,600,00019,800,00019,866,00019,900,00019,900,00017,544,72017,400,00018,000,00018,000,000121,030153,380153,380422,430621,890738,0301,025,700409,45024,435,89600000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,435,896
409,450
1,025,700
738,030
621,890
422,430
153,380
153,380
121,030
9,842,903
9,968,278
0
0
0
0
0
0
0
0
0
0
0
19,458,250
16,850,000
20,350,000
20,300,000
20,300,00020,350,00016,850,00019,458,250000000000009,968,2789,842,903121,030153,380153,380422,430621,890738,0301,025,700409,45024,435,89600000000000000000
       Accounts payable 
11,186,343
9,333,535
6,863,764
9,536,888
5,130,609
12,632,121
10,853,397
15,601,656
13,813,244
13,602,270
13,049,858
16,046,981
15,948,439
8,692,318
12,627,846
17,243,379
15,694,768
11,918,041
13,744,002
17,850,463
16,702,317
12,231,824
14,616,674
12,812,901
14,655,302
9,826,018
9,769,400
10,554,845
7,556,915
7,842,090
10,227,054
9,047,874
10,065,533
7,676,779
8,336,630
0
0
11,445,282
11,214,071
12,642,869
13,763,103
13,464,203
15,117,055
15,117,05513,464,20313,763,10312,642,86911,214,07111,445,282008,336,6307,676,77910,065,5339,047,87410,227,0547,842,0907,556,91510,554,8459,769,4009,826,01814,655,30212,812,90114,616,67412,231,82416,702,31717,850,46313,744,00211,918,04115,694,76817,243,37912,627,8468,692,31815,948,43916,046,98113,049,85813,602,27013,813,24415,601,65610,853,39712,632,1215,130,6099,536,8886,863,7649,333,53511,186,343
       Other Current Liabilities 
15,727,100
8,700,295
9,399,203
6,535,464
13,498,431
9,291,425
9,237,280
16,027,834
10,752,265
11,036,501
9,618,314
12,187,420
10,694,352
9,075,596
7,224,914
11,302,980
15,086,095
13,745,978
10,970,363
20,624,669
20,876,582
15,725,955
15,172,989
18,861,716
20,144,120
7,760,747
17,733,918
16,655,450
14,446,588
14,252,922
11,754,177
13,970,634
17,340,400
14,345,723
14,747,852
0
0
14,749,181
17,269,153
0
20,813,379
-1
0
0-120,813,379017,269,15314,749,1810014,747,85214,345,72317,340,40013,970,63411,754,17714,252,92214,446,58816,655,45017,733,9187,760,74720,144,12018,861,71615,172,98915,725,95520,876,58220,624,66910,970,36313,745,97815,086,09511,302,9807,224,9149,075,59610,694,35212,187,4209,618,31411,036,50110,752,26516,027,8349,237,2809,291,42513,498,4316,535,4649,399,2038,700,29515,727,100
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,742,724
7,778,627
8,061,746
8,350,458
8,350,4588,061,7467,778,6277,742,724000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
829,913
547,838
459,661
440,906
310,757
402,013
310,673
318,023
285,992
233,942
257,250
307,965
253,318
210,133
173,099
145,664
0
0145,664173,099210,133253,318307,965257,250233,942285,992318,023310,673402,013310,757440,906459,661547,838829,91300000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-24,435,896
-409,450
-1,025,700
-738,030
-621,890
-422,430
-153,380
-153,380
-121,030
-18,000,000
-18,000,000
-17,400,000
-17,544,720
-19,900,000
-19,900,000
-19,866,000
-19,800,000
-19,600,000
-19,600,000
-19,600,000
-19,600,000
-19,450,000
-18,903,353
-16,422,683
-20,022,851
420,948
420,948-20,022,851-16,422,683-18,903,353-19,450,000-19,600,000-19,600,000-19,600,000-19,600,000-19,800,000-19,866,000-19,900,000-19,900,000-17,544,720-17,400,000-18,000,000-18,000,000-121,030-153,380-153,380-422,430-621,890-738,030-1,025,700-409,450-24,435,89600000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
-3
0
0-310000000000000000000000000000000000000000
> Total Stockholder Equity
114,739,790
115,592,358
117,702,322
125,888,244
126,562,212
125,072,812
127,614,101
121,728,079
122,095,466
126,596,635
132,717,113
131,062,087
129,203,359
128,556,293
128,733,327
130,892,987
130,218,768
132,886,683
137,012,268
136,958,034
136,457,357
139,765,579
141,365,164
146,766,161
145,746,558
145,460,550
146,928,536
148,246,515
149,012,367
144,508,287
144,803,580
144,098,415
142,694,788
141,599,807
143,084,588
145,260,923
143,615,267
144,652,499
154,831,591
154,797,698
154,589,329
155,053,212
154,461,562
154,461,562155,053,212154,589,329154,797,698154,831,591144,652,499143,615,267145,260,923143,084,588141,599,807142,694,788144,098,415144,803,580144,508,287149,012,367148,246,515146,928,536145,460,550145,746,558146,766,161141,365,164139,765,579136,457,357136,958,034137,012,268132,886,683130,218,768130,892,987128,733,327128,556,293129,203,359131,062,087132,717,113126,596,635122,095,466121,728,079127,614,101125,072,812126,562,212125,888,244117,702,322115,592,358114,739,790
   Common Stock
5,885,469
5,885,469
5,885,469
6,355,268
6,355,268
6,425,759
6,464,507
6,464,507
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
6,521,210
0
06,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,521,2106,464,5076,464,5076,425,7596,355,2686,355,2685,885,4695,885,4695,885,469
   Retained Earnings 
107,489,532
107,642,665
109,614,165
0
0
0
0
0
0
0
0
0
0
0
0
0
0
115,555,598
119,672,888
119,700,588
118,856,792
122,021,152
124,608,758
129,902,606
128,887,001
127,528,073
129,007,256
130,170,214
130,959,646
126,446,691
126,738,444
126,214,828
124,814,141
123,584,491
125,031,698
127,754,389
126,501,193
127,692,997
131,569,798
133,486,572
133,671,520
134,360,547
135,030,447
135,030,447134,360,547133,671,520133,486,572131,569,798127,692,997126,501,193127,754,389125,031,698123,584,491124,814,141126,214,828126,738,444126,446,691130,959,646130,170,214129,007,256127,528,073128,887,001129,902,606124,608,758122,021,152118,856,792119,700,588119,672,888115,555,59800000000000000109,614,165107,642,665107,489,532
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,178,882
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
14,313,121
0
014,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,313,12114,178,88200000000000000000000000000
   Treasury Stock0000000-4,386,985-3,951,842-3,951,842-3,951,842-3,967,048-3,951,842-3,951,842-3,951,842-3,951,842-3,951,842000-3,951,842-3,951,842-3,967,048-3,967,048-3,967,048-3,967,048-3,967,048-3,969,439-3,962,323-3,969,835-3,970,860-3,972,511-3,981,910-3,981,910-3,968,561-3,968,561-3,971,804-3,971,114-3,976,684-3,976,684-3,961,425-3,961,425-3,977,774
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
180,417
423,006
330,992
674,111
817,973
-170,048
-62,899
-66,897
-34,061
1,218,287
-24,476
-48,057
-39,181
-597,916
-217,190
-220,130
-85,461
-47,887
1,218,288
1,218,288
-152,136
-149,353
4,199,488
3,806,171
1,218,288
0
01,218,2883,806,1714,199,488-149,353-152,1361,218,2881,218,288-47,887-85,461-220,130-217,190-597,916-39,181-48,057-24,4761,218,287-34,061-66,897-62,899-170,048817,973674,111330,992423,006180,41700000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.